How is the 383,531-share beneficial ownership of Sight Sciences (SGHT) by Jeremy B. Hayden composed?

The 383,531 beneficially owned shares comprise two main components: 75,562 shares of common stock currently held, and 307,969 additional shares of common stock that will be received upon future vesting and settlement of unvested restricted stock units, assuming service-based vesting conditions are satisfied.

Sight Sciences awards 115,920 RSUs to legal chief

Q: What insider transaction did Sight Sciences (SGHT) report for Jeremy B. Hayden?

Sight Sciences reported a grant of 115,920 RSUs of common stock to Chief Legal Officer Jeremy B. Hayden on February 3, 2026 at a price of $0 per share. The award was made under the company’s 2021 Incentive Award Plan, as disclosed in the Form 4 filing.

Q: What is the vesting schedule for Jeremy B. Hayden’s 115,920 RSUs at Sight Sciences (SGHT)?

The 115,920 RSUs vest in 16 equal quarterly installments starting March 31, 2026. Vesting continues through December 31, 2029, and each quarterly tranche requires Hayden’s continued service with Sight Sciences on the applicable vesting date to receive the underlying common shares.

Sight Sciences, Inc. reported that Chief Legal Officer Jeremy B. Hayden received an award of 115,920 restricted stock units (RSUs) of common stock on February 3, 2026 under the company’s 2021 Incentive Award Plan, at a price of $0 per share.

Accepted by SEC EDGAR 02/05/2026 - 04:49 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Sight Sciences, Inc. reported that Chief Legal Officer Jeremy B. Hayden received an award of 115,920 restricted stock units (RSUs) of common stock on February 3, 2026 under the company’s 2021 Incentive Award Plan, at a price of $0 per share.

The RSUs vest in 16 equal quarterly installments from March 31, 2026 through December 31, 2029, contingent on his continued service. Each RSU converts into one share of common stock. After this grant, Hayden beneficially owns 383,531 shares, including 75,562 shares of common stock and 307,969 shares underlying unvested RSUs.

Insider Trade Summary

Grant/Award: 115,920 shares

Grant/Award 1 txn

Insider HAYDEN JEREMY B.

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	115,920	$0.00	$0.00

Holdings After Transaction: Common Stock — 383,531 shares (Direct)

Footnotes (2)

F1. Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing March 31, 2026 and continuing through December 31, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $750,000 divided by the closing price of the Common Stock on the grant date, which was February 3, 2026.
F2. Includes (i) 75,562 shares of Common Stock, and (ii) 307,969 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sight Sciences (SGHT) report for Jeremy B. Hayden?

Sight Sciences reported a grant of 115,920 RSUs of common stock to Chief Legal Officer Jeremy B. Hayden on February 3, 2026 at a price of $0 per share. The award was made under the company’s 2021 Incentive Award Plan, as disclosed in the Form 4 filing.

What is the vesting schedule for Jeremy B. Hayden’s 115,920 RSUs at Sight Sciences (SGHT)?

The 115,920 RSUs vest in 16 equal quarterly installments starting March 31, 2026. Vesting continues through December 31, 2029, and each quarterly tranche requires Hayden’s continued service with Sight Sciences on the applicable vesting date to receive the underlying common shares.

How many Sight Sciences (SGHT) shares does Jeremy B. Hayden beneficially own after this Form 4 transaction?

After the grant, Jeremy B. Hayden beneficially owns 383,531 shares of Sight Sciences common stock. This total includes 75,562 currently held shares and 307,969 shares that will be acquired upon the vesting and settlement of restricted stock units that have not yet vested.

Under which equity plan were the 115,920 RSUs granted to Sight Sciences (SGHT) Chief Legal Officer?

The RSUs were granted under Sight Sciences’ 2021 Incentive Award Plan. This plan provides equity-based compensation such as restricted stock units. Hayden’s February 3, 2026 award reflects a grant sized by dividing $750,000 by the common stock closing price on the grant date.

What does each restricted stock unit (RSU) granted to Sight Sciences (SGHT) Chief Legal Officer represent?

Each RSU represents a contingent right to receive one share of Sight Sciences common stock, par value $0.001 per share. Delivery of shares occurs as the RSUs vest between March 31, 2026 and December 31, 2029, conditioned on Jeremy B. Hayden’s continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HAYDEN JEREMY B.

(Last)

(First)

(Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK

94025

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/03/2026		A		115,920⁽¹⁾	A	$0	383,531⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing March 31, 2026 and continuing through December 31, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $750,000 divided by the closing price of the Common Stock on the grant date, which was February 3, 2026.

2. Includes (i) 75,562 shares of Common Stock, and (ii) 307,969 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

	/s/Jeremy Hayden	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR